Pasgala, Baby Boy .
HRN: 22-76-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/29/2023
04/04/2023
IVTT
29mg
Q24h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes